Lijin Zeng
- Co-authors
- Jingguo WuYanbing LiangHao TangZhong-fu MaWen YangZhibin ChenZhenyu LiHui Ming Ge
- Topics
- Immune cells in cancer (4 papers)Multiple Myeloma Research and Treatments (2 papers)Immune Cell Function and Interaction (2 papers)
- Cited by
- ImmunologyParasitologyPharmacology
In The Last Decade
Lijin Zeng
18 papers receiving 401 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 136
- Immunology 129
- Oncology 53
- Physiology 37
- Parasitology 37
Countries citing papers authored by Lijin Zeng
This map shows the geographic impact of Lijin Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijin Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijin Zeng more than expected).
Fields of papers citing papers by Lijin Zeng
This network shows the impact of papers produced by Lijin Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijin Zeng. The network helps show where Lijin Zeng may publish in the future.
Co-authorship network of co-authors of Lijin Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Lijin Zeng. A scholar is included among the top collaborators of Lijin Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijin Zeng. Lijin Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 7 | |
| 4 | 21 | |
| 5 | 2 | |
| 6 | Osthole attenuates myocardial ischemia/reperfusion injury in rats by inhibiting apoptosis and inflammation. | 12 |
| 7 | 88 | |
| 8 | 95 | |
| 9 | 7 | |
| 10 | 38 | |
| 11 | 36 | |
| 12 | 1 | |
| 13 | 22 | |
| 14 | 15 | |
| 15 | [Expression and effects of microRNA-155 in the livers of septic mice]. | 5 |
| 16 | 27 | |
| 17 | 18 | |
| 18 | [Combination of bortezomib and dexamethasone for newly diagnosed multiple myeloma]. | 2 |
About Lijin Zeng
Lijin Zeng is a scholar working on Applied Microbiology and Biotechnology, Immunology and Toxicology, having authored 18 papers that have together received 404 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Multiple Myeloma Research and Treatments (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (129 citations), Parasitology (37 citations) and Pharmacology (36 citations). Lijin Zeng has collaborated with scholars based in China and Macao. Frequent co-authors include Jingguo Wu, Yanbing Liang, Hao Tang, Zhong-fu Ma, Wen Yang, Zhibin Chen, Zhenyu Li, Hui Ming Ge, Qing Yang and Zhenyu Li. Their work appears in journals such as Journal of Materials Chemistry, Journal of Cellular Physiology and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.